The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus

Voprosy Virusologii

Volumn 56, Issue 1, 2011, Pages 17-21

  Kiselev, O I ^a   Komissarov, A B ^a   Stukova, M A ^a   Buzitskaya, Zh V ^a   Pisareva, M M ^a   Elpaeva, E A ^a   Danilenko, D M ^a   Konovalova, N I ^a   Gudkova, T T ^a   Grigoryeva, V A ^a   Smirnova, T S ^a   Slita, A V ^a   Romanovskaya Romanko, E A ^a   Tsybalova, L M ^a   Sominina, A A ^a   Eropkin, M Yu ^a   Grudinin, M P ^a  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Antigenic properties; Hemagglutinin; Pandemic influenza A(H1N1v) virus; Phylogenetic analysis; Resistance

Indexed keywords

INFLUENZA A VIRUS; INFLUENZAVIRUS A;

ADAMANTANINE; AMANTADINE; ANTIVIRUS AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; HEMAGGLUTININ; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN; OSELTAMIVIR; SIALIDASE; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANIMAL; ANTIVIRAL RESISTANCE; ARTICLE; CHICK EMBRYO; CHILD; DRUG EFFECT; GENETIC REASSORTMENT; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; LUNG; MEXICO; MIDDLE AGED; MORTALITY; NASOPHARYNX; PANDEMIC; PHYLOGENY; PRESCHOOL CHILD; RUSSIAN FEDERATION; TRACHEA; UNITED STATES; VIROLOGY;

ADOLESCENT; ADULT; AGED; AMANTADINE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CHICK EMBRYO; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; MEXICO; MIDDLE AGED; MORTALITY; NASOPHARYNX; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; PHYLOGENY; REASSORTANT VIRUSES; RUSSIA; TRACHEA; UNITED STATES; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; YOUNG ADULT;

EID: 79960909443     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Gambaryan A. S., Robertson J. S., Mairosovich M. N. Effects of egg adaptation on the receptor-binding properties of human influenza A and B viruses // Virology. -1999. -Vol. 258. P. 232-239.
2. Garten R. J., Davis C. F., Russell C. A. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza vimses circulating in humans // Science. -2009. -Vol. 325. - P. 197.
3. Kendal A. P., Goldfield M., Noble G. R, Dowdle W. R. Identification and preliminary antigenic analysis of swine influenzalike viruses isolated during an influenza outbreak at Fort Dix, New Jersey // J. Infect. Dis. -1977. - Suppl. - P. 381-385.
4. Nicholls J. M., Bourne A. J., Chen H. et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza vimses // Respir. Res. -2007. -Vol. 8. -P. 73.
5. 2009 Pandemic influenza A(H1N1) vims mutations reported to be associated with severe disease (23 Dec. 2009). http:// ecdc.europa.eu/en/activities/ sciadvice
6. Shen J., Ma J., Wang Q. Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918 // PloS One. -2009. -Vol.4, N 11. -P. e7789.
7. Tumpey F. M., Maines F. R., Van Hoeven N. et al. A two-amino acid change in the hemagglutinin of the 1918 influenza vims abolishes transmission // Science. -2007. -Vol. 315. P. 655-659.
8. Xu X., Rocha E. P., Regenery H. L. et al. Genetic and antigenic analyses of influenza A(H1N1) viruses, 1986-1991 // Vims Res. - 1993. - Vol. 28. - P. 37-55.